We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
An image displaying a Newsletter on tablet, laptop & mobile

To continue reading this article, sign up for FREE to

Technology Networks logo


Membership is FREE and provides you with instant access to email newsletters, digital publications, our full content catalogue & more...

CyGenics’ Subsidiary Signs Distribution Agreement with CombiMatrix

Read time: Less than a minute

CyGenics Limited has announced that its wholly-owned subsidiary, Cell Sciences Ltd, has entered into a nonexclusive distribution agreement with CombiMatrix group of Acacia Research Corporation to distribute CombiMatrix products and services in Singapore.

Under the terms of the agreement, Cell Sciences will market and sell CustomArrays™, CatalogArrays™ and CustomArray Synthesizers, which are semiconductor-based tools for use in identifying and determining the roles of genes, and the recently introduced Influenza Research Microarray, to the Southeast Asian market.

"We are very pleased to have expanded our distribution network into Southeast Asia," said Michael Tognotti, Vice President of Sales and Marketing for CombiMatrix.

"I am confident that by joining forces with Cell Sciences, we can accelerate sales growth and enhance our collective market share."

"Cell Sciences has identified CombiMatrix’s platform technology to rapidly produce customizable arrays for applications in the areas of proteomics, genomics and nanotechnology," said Mr Steven Fang, Group CEO, CyGenics.

"This has a huge market potential in the Asia Pacific region and we look forward to a long and fruitful relationship."